Figure 2: Systolic Blood Pressure (SBP) Mean change from baseline in SBP vs time. (A) Single dose. (B) Repeat dose....
BBS-Bioactive Bone Substitutes Plc, Company Announcement, Insider Information, 3 October 2023 at 4.00 p.m. (EET) Insider information: BBS-Bioactive Bone Substitutes...
PALO ALTO, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating...
ALBANY, N.Y., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Certified Testing & Data (CTND) and Nova Analytic Labs (Nova) announced a...
LOS ANGELES, Oct. 03, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced approval of the Monarch eTNS System by Singapore’s Health...
Radicle Science studied MDSleep in one of history’s largest clinical trials on a supplement brand’s sleep formulation.Los Angeles, CA, Oct....
Expands access to vertebrogenic pain treatment for 36 million patientsMINNEAPOLIS, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company...
The randomized pivotal Phase 3 study is expected to enroll a total of 354 patients in either Bria-IMT™ combination or...
Cannabix Technologies Inc. Cannabix Technologies MSBS and BCU Figures 1 and 2 VANCOUVER, British Columbia, Oct. 03, 2023 (GLOBE NEWSWIRE)...
Program provides healthcare providers access to Diagnamed’s novel brain health AI platform Figure 1. Demonstration of CERVAI™ Brain Age™ SessionTORONTO,...
Dr. Sudhir Srivastava, a world-leading cardiac surgeon, performed the world’s first beating heart robotic cardiac bypass surgery using the SSi...
Begins revenue generation for “Camelina Seed Genetics to Biofuel” platformWOBURN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc....
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent...
BLOOMFIELD HILLS, Mich, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company...
Cleared First Three Monotherapy Cohorts with No Dose Limiting Toxicity and No Consistent Pattern of Adverse Events at any Dose...
Efficacy of the Three Most Commonly Used MIGS Technologies plus Cataract Surgery and Cataract Surgery Alone Were Evaluated and Compared...
NEVE ILAN, Israel and SALT LAKE CITY, Oct. 03, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,”...
WATERTOWN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
– Femasys demonstrates compliance with harmonized regulatory requirements for Australia, Brazil, Japan, Canada and the USA – – Femasys is committed...
GREENVILLE, SC, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Zylö Therapeutics has been selected to join the Endless Frontier Labs (EFL)...